Table 1.
Reported outcomes and their follow up periods
| Study | Reported outcomes | Follow up periods | Type of follow up |
|---|---|---|---|
| Bhurke 2012 [17] | MI and revascularization | 9 months | Short term |
| Burkard 2012 [18] | Death, MI, ST, MACE, TVR | 3 years | Long term |
| Chitose 2012 [19] | Death, MI | 18 months | Long term |
| Douglas 2012 [20] | Death, MI | 10 months | Short term |
| Dunn 2013 [21] | Death, MI, TVR | 1 month | Short term |
| Goodman 2012 [22] | Death, MI, ST | 1 year | Long term |
| Hsieh 2015 [23] | MI, revascularization | 1 year | Long term |
| Macaione 2012 [24] | Death, MI, TVR | 3 years | Long term |
| Weisz 2015 [25] | Death, MACEs, MI, ST, TVR | In hospital, 2 years | Short and long term |
| Zou 2014 [26] | Death, MACEs, MI, ST, TVR | 1 year | Long term |
| Gargiolo 2016 [16] | Death, MACEs, MI, ST | 2 years | Long term |
Abbreviations: MI Myocardial infarction, ST Stent thrombosis, MACEs Major adverse cardiac events, TVR Target vessel revascularization